Visiox Pharma Licenses OMLONTI®

TARRYTOWN, N.Y., July 19, 2023 /PRNewswire/ -- Visiox Pharma, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to address highly prevalent diseases in need of new treatment options, today announced it has entered into...